[Clinical importance of monophasic action potential registration in long QT syndrome].
For more than 30 years, the monophasic action potential has been used as an experimental tool for the study of myocardial repolarisation. With recent improvements in catheter design, the utility of the tool as a means to identify the bases for ventricular arrhythmias in humans has been greatly improved. Abnormalities of repolarisation leading to ventricular arrhythmia formation can be identified and specific pharmacological therapies may be evaluated. The pathomechanism of major arrhythmias (ventricular tachycardia, ventricular fibrillation) occurring in long QT syndrome (LQTS) is not yet fully elucidated. The authors have recorded the monophasic action potentials (MAP) of the right ventricle in three patients with LQTS and with previous episodes of major ventricular arrhythmias. The changes in MAP duration and after depolarisation in response to spontaneous arrhythmias, programmed electrostimulation, atrial pacing and isoproterenol treatment were studied. In all of the three patients the early afterdepolarisation was present, which in two cases exhibited pause-dependent features. Thus in these patients dual chamber pacemaker implantatious were performed. These were the first permanent recordings of MAP during electrophysiological examination in Hungary and also the first evidences that the early afterdepolarisation does play a pathogenic role in the development of idiopathic LQTS. Further evaluation of the technique by cardiac electro-physiologists may improve both the diagnosis and the treatment of ventricular arrhythmias dependent upon afterdepolarisation formation.
Merkely
B
B
Semmelweis Orvostudományi Egyetem, Budapest.
Tomcsányi
J
J
Tenczer
J
J
Vecsey
T
T
Gyöngy
T
T
Solti
F
F
Bodor
E
E
D000200:Action Potentials; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004562:Electrocardiography; D006801:Humans; D008133:Long QT Syndrome / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D017180:Tachycardia, Ventricular / Q000503:physiopathology* / Q000628:therapy; D014693:Ventricular Fibrillation / Q000503:physiopathology* / Q000628:therapy
D002121:Calcium Channel Blockers
Monofázisos akciós potenciál regisztrálás klinikai jelentösége hosszú QT-szindrómában.